Guru Ownership Trend
Guru Analysis for Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.18 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $260,866.3 net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 22.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Lyell Immunopharma, Inc. (LYEL)
Major holders include Renaissance Technologies (RenTech) ($1.83 M), Steven Cohen ($366,424). According to the latest reported data, 2 tracked investment managers collectively hold approximately 156,270 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $260,866.3, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in LYEL during the most recent reporting period.
Yes, 0 managers opened new positions in LYEL, and 2 increased their existing holdings. The total reported buy value was $260,866.3.